Bank of New York Mellon »

Tempest Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2023-12-31 $61k 14k 4.40

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Ishares Core S&p 500 Etf Core (IVV)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Mastercard Inc - A Cl A (MA)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)

View all positions for Bank of New York Mellon

Top funds holding Tempest Therapeutics

Vanguard Group
Ikarian Capital
Two Sigma Investments
Citadel Advisors
Simplex Trading
Bank of America Corporation
Two Sigma Securities
Advisor Group Holdings
Virtu Financial
Tocqueville Asset Management
Schonfeld Strategic Advisors
Bank Of Montreal
MayTech Global Investments
Cutler
UBS Group

View all funds holding Tempest Therapeutics